Edition:
United States

Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

51.20USD
3:59pm EST
Change (% chg)

$1.35 (+2.71%)
Prev Close
$49.85
Open
$50.45
Day's High
$52.90
Day's Low
$50.45
Volume
37,934
Avg. Vol
51,415
52-wk High
$55.95
52-wk Low
$17.15

Chart for

About

Foundation Medicine, Inc. is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and... (more)

Overall

Beta: -0.08
Market Cap(Mil.): $1,807.19
Shares Outstanding(Mil.): 36.25
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 200.64 15.49
EPS (TTM): -- -- --
ROI: -- -10.01 11.95
ROE: -- -35.77 15.94

BRIEF-Foundation Medicine Q3 loss per share $0.90

* Foundation Medicine announces 2017 third quarter results and recent highlights

Nov 01 2017

BRIEF-Foundation Medicine receives approval from state of New York for foundation act liquid biopsy assay

* Foundation Medicine Inc - receives approval from state of New York for foundation act liquid biopsy assay Source text for Eikon: Further company coverage:

Oct 02 2017

BRIEF-Foundation Medicine and Roche enters into a fifth amendment to Collaboration Agreement

* Foundation Medicine Inc - On September 8, company and Roche entered into a fifth amendment to Collaboration Agreement - SEC filing

Sep 13 2017

BRIEF-Foundation Medicine Q2 revenue $35 mln

* Foundation Medicine announces 2017 second quarter results and recent highlights

Aug 01 2017

BRIEF-Foundation Medicine entered into amendment letter agreement with Roche Finance

* Foundation Medicine Inc - co entered into amendment letter agreement with Roche Finance Ltd amending credit facility agreement, dated August 2, 2016

Aug 01 2017

BRIEF-Kura Oncology ‍enters into collaboration agreement with Foundation Medicine ​

* Kura Oncology Inc - ‍entered into a collaboration agreement with Foundation Medicine, Inc.​

Jul 13 2017

Earnings vs. Estimates